Home / About PPME / News
News
Generic substitution in Norway
2011-12-09 Using a dataset extracted from the Norwegian prescription database containing all prescriptions written in the period January 2004 to June 2007, an analysis was carr...
Read more
Falsified medicines law approved by European Parliament
2011-12-08 Following many months of negotiations, a new law to prevent fake medicines from entering the supply chain was finally approved by the European Parliament on 16 Febru...
Read more
EMA proposes more precise definition for biosimilars
2011-12-07 Members of the Biosimilar Medicinal Products Working Party at the EMA expressed the need to propose a more precise definition for biosimilars due to problems arising...
Read more
Europe’s industry concerned about converging prices and patient access
2011-12-06 In response to a report on reference pricing in the EU, the European Federation of the Pharmaceutical Industries and Associations (EFPIA) says that while ‘it is rati...
Read more
Tendering for medicines in ambulatory care
2011-12-05 Tendering is a mechanism whereby a purchaser buys medicines from the pharmaceutical manufacturer that offers the best bid [1]. Whereas tendering is widely used in th...
Read more
EU patent with 23 countries
2011-12-02 The patent deadlock may yet be over, as 23 members of the EU have decided to leave behind the four others and work together to create a single patent system to prote...
Read more
Overprescribing of drugs ‘chronic’ in Europe
2011-12-01 Salzburg Medical University, Austria, is the latest body to report the ‘chronic’ overprescribing of drugs for the elderly in Europe. The study found that 36% of pres...
Read more
Timing of the launch of biosimilars in Europe
2011-11-30 In Europe, there is a mutual recognition process for the regulatory process leading to the licensing of biosimilars for sale in all countries within the EU. However,...
Read more
Rituximab biosimilar successfully produced in plants
2011-11-29 iBio, a leader in the plant-made pharmaceutical field, announced on 5 October 2011 that it had successfully expanded the use of its technology to biosimilar monoclon...
Read more
Concerns over international reference pricing in the EU
2011-11-28 An independent report commissioned by the European Parliament’s committee for Environment, Public Health and Food Safety (ENVI) has highlighted some problems with ac...
Read more
How successful is the reference pricing system in Belgium
2011-11-25 The main aim of a reference pricing system (RPS) is to provide generic medicines at the lowest cost to the state and individuals. This article explains how RPSs work...
Read more
Scottish government considering generic substitution
2011-11-24 A Scottish politician revealed on 17 November 2010 that the Scottish government is currently considering whether to introduce generic substitution as part of ongoing...
Read more
Last update: 2008-09-06 | 
Go Back | 
Print View
